| Autor: |
Feigin A; New York University Langone Health and The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York, NY, USA., Evans EE; Vaccinex, Inc., Research, Rochester, NY, USA., Fisher TL; Vaccinex, Inc., Research, Rochester, NY, USA., Leonard JE; Vaccinex, Inc., Research, Rochester, NY, USA., Smith ES; Vaccinex, Inc., Research, Rochester, NY, USA., Reader A; Vaccinex, Inc., Research, Rochester, NY, USA., Mishra V; Vaccinex, Inc., Research, Rochester, NY, USA., Manber R; IXICO, London, UK., Walters KA; WCG Statistics Collaborative, Inc., Washington, DC, USA., Kowarski L; WCG Statistics Collaborative, Inc., Washington, DC, USA., Oakes D; University of Rochester Medical Center, Rochester, NY, USA., Siemers E; Siemers Integration LLC, Zionsville, IN, USA., Kieburtz KD; University of Rochester Medical Center, Rochester, NY, USA., Zauderer M; Vaccinex, Inc., Research, Rochester, NY, USA. mzauderer@vaccinex.com. |
Full text from SpringerLink